Conquering Diseases

Study Of An Investigational Drug In Adult Patients With A Specific Kind Of Recurrent Brain Cancer

Description

Seeking men and woment 18 years of age or older who have been diagnosed with recurrent glioblastoma multiforme and who have failed standard first line therapy.

Overview

We are studying the investigational drug berubicin to determine how well it works compared to the standard therapy in treating recurrent glioblastoma multiforme.

What we're hoping for

Evaluate how safety, tolerable, and well, the investigational drug berubicin works compared to the standard therapy in treating recurrent glioblastoma multiforme.

Additional Information

ClinicalTrials.gov Identifier: NCT04762069

 Principal Investigator

David  Cachia, MD

UMass Memorial Health Care

 Study Contact

The Cancer  Research Office

508-856-3216

Cancer.research@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989